![Karen M. Kumor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen M. Kumor
Chief Tech/Sci/R&D Officer at Sapphire Therapeutics, Inc.
Profile
Karen M.
Kumor is currently working as Vice President-Clinical Research at Sapphire Therapeutics, Inc. She has a graduate and doctorate degree from The Johns Hopkins University.
Karen M. Kumor active positions
Companies | Position | Start |
---|---|---|
Sapphire Therapeutics, Inc.
![]() Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 12/10/2009 |
Training of Karen M. Kumor
The Johns Hopkins University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Sapphire Therapeutics, Inc.
![]() Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Karen M. Kumor